Quan Venture Fund Ii, L.P. Design Therapeutics, Inc. (DSGN) insider trading activity

DSGN Quotes by TradingView

Quan Venture Fund Ii, L.P. is > 10% Shareholder of Design Therapeutics, Inc.. Currently has a direct ownership of 4.72 Million shares of DSGN, which is worth approximately $26.5 Million. The most recent transaction as insider was on Mar 30, 2021, when has been sold 4,720,830 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.72M
0% 3M change
0% 12M change
Total Value Held $26.5 Million

Quan Venture Fund II, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 30 2021
BUY
Conversion of derivative security
-
4,720,830 Added 50.0%
4,720,830 Common Stock
QVF

Quan Venture Fund Ii, L.P.

> 10% Shareholder
Grand Cayman, E9

Track Institutional and Insider Activities on DSGN

Follow Design Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DSGN shares.

Notify only if

Insider Trading

Get notified when an Design Therapeutics, Inc. insider buys or sells DSGN shares.

Notify only if

News

Receive news related to Design Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DSGN